Glenmark Pharmaceuticals Ltd
NSE: GLENMARK BSE: 532296
₹2136.70
(0.58%)
Sun, 08 Mar 2026, 07:19 pm
Market Cap603.26B
PE Ratio56.64
Dividend0.23
Health Technology
Pharmaceuticals: Major
24.5KGlenmark Pharmaceuticals Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.76B | 11.89B | 19.34B | 20.40B | 24.33B | 29.49B | 40.21B | 50.12B | 59.24B | 65.22B | 75.62B | 90.79B | 90.74B | 97.25B | 105.45B | 108.58B | 123.05B | 115.83B | 118.13B | 133.22B |
| Gross profit | 2.93B | 6.53B | 11.30B | 9.21B | 11.12B | 13.52B | 19.48B | 24.43B | 30.01B | 32.79B | 34.05B | 49.21B | 43.45B | 31.91B | 34.30B | 36.32B | 42.39B | 36.30B | 32.59B | 48.15B |
| Operating expenses (excl. COGS) | -1.82B | -2.73B | -4.07B | -5.77B | -5.83B | -8.55B | -13.32B | -15.61B | -19.21B | -23.94B | -22.36B | -34.60B | -30.82B | -20.40B | -22.15B | -19.67B | -23.57B | -25.29B | -26.09B | -29.19B |
| Selling/general/admin expenses, total | -1.75B | -2.66B | -3.94B | -5.63B | -5.59B | -8.55B | -13.32B | -15.61B | -19.21B | -23.94B | -22.36B | -34.60B | -30.82B | -20.26B | -21.95B | -19.29B | -23.29B | -25.19B | -26.03B | -28.93B |
| Research & development | -263.34M | -432.61M | -757.73M | -882.70M | -772.76M | -1.38B | -2.92B | -4.12B | -6.00B | -6.01B | -8.18B | -12.62B | -12.25B | -14.48B | -13.21B | -13.19B | -12.79B | -12.50B | -12.26B | -9.73B |
| Selling/general/admin expenses, other | -1.49B | -2.23B | -3.18B | -4.75B | -4.81B | -7.17B | -10.40B | -11.49B | -13.22B | -17.93B | -14.18B | -21.98B | -18.57B | -5.78B | -8.75B | -6.10B | -10.51B | -12.69B | -13.77B | -19.20B |
| Other operating expenses, total | -68.03M | -71.92M | -128.35M | -137.71M | -242.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -142.71M | -197.41M | -386.67M | -277.44M | -101.62M | -63.44M | -256.45M |
| Operating income | 1.11B | 3.80B | 7.23B | 3.44B | 5.29B | 4.98B | 6.16B | 8.83B | 10.80B | 8.84B | 11.69B | 14.60B | 12.63B | 11.51B | 12.15B | 16.65B | 18.82B | 11.01B | 6.50B | 18.96B |
| Non-operating income, total | -20.59M | -227.08M | -196.90M | -834.72M | -1.45B | -160.40M | -1.28B | -1.49B | -3.83B | -2.90B | -1.64B | -2.00B | -1.97B | 1.50B | -1.19B | -2.83B | -4.41B | -8.61B | -6.14B | -4.97B |
| Interest expense, net of interest capitalized | -181.67M | -398.26M | -710.42M | -1.46B | -1.66B | -1.60B | -1.47B | -1.60B | -1.89B | -1.90B | -1.79B | -2.37B | -2.86B | -3.35B | -3.77B | -3.53B | -2.98B | -3.49B | -5.16B | -2.07B |
| Interest capitalized | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 23.47M | 25.50M | 209.98M | 219.25M | 187.71M | 162.43M | 150.00M | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 161.08M | 171.17M | 513.51M | 1.79B | 205.14M | 1.44B | 181.73M | 107.47M | 232.18M | -999.50M | 200.00M | 372.90M | 889.87M | 6.62B | 2.44B | 705.60M | 1.18B | -5.12B | -977.74M | 830.07M |
| Non-operating interest income | 34.48M | 14.18M | 78.74M | 52.44M | 14.82M | 38.97M | 89.12M | 42.62M | 66.44M | 14.31M | 75.80M | 180.69M | 89.36M | 27.00M | 46.76M | 26.47M | 94.35M | 70.00M | 61.76M | 439.35M |
| Miscellaneous non-operating expense | 126.61M | 156.99M | 434.78M | 1.74B | 190.32M | 1.41B | 92.61M | 64.85M | 165.74M | -1.01B | 124.20M | 192.21M | 800.51M | 6.59B | 2.40B | 679.13M | 1.08B | -5.19B | -1.04B | 390.72M |
| Unusual income/expense | — | — | — | -1.17B | — | — | — | — | -2.18B | — | -56.11M | — | — | -1.78B | 143.22M | 0 | -2.61B | 0 | 0 | -3.73B |
| Pretax income | 1.09B | 3.57B | 7.03B | 2.61B | 3.84B | 4.82B | 4.88B | 7.34B | 6.97B | 5.94B | 10.05B | 12.60B | 10.67B | 13.01B | 10.96B | 13.82B | 14.41B | 2.40B | 364.95M | 13.99B |
| Taxes | -207.09M | -472.62M | -708.60M | -672.42M | -528.46M | -237.20M | -237.84M | -1.11B | -1.51B | -1.19B | -3.03B | -3.44B | -2.93B | -3.76B | -3.20B | -4.12B | -4.48B | -3.29B | -18.67B | -3.52B |
| Non-controlling/minority interest | 0 | 0 | 204.00K | -18.09M | -65.61M | -46.25M | -39.59M | -82.57M | -33.28M | 700.00K | 1.93M | 460.00K | -920.00K | -110.00K | -30.00K | -500.00K | -519.38M | -801.55M | -681.46M | -450.00K |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.00K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 879.76M | 3.10B | 6.32B | 1.92B | 3.24B | 4.53B | 4.60B | 6.15B | 5.42B | 4.75B | 7.02B | 9.16B | 7.74B | 9.25B | 7.76B | 9.70B | 9.42B | -1.70B | -18.99B | 10.47B |
| Net income | 879.76M | 3.10B | 6.32B | 1.92B | 3.24B | 4.53B | 4.60B | 6.15B | 5.42B | 4.75B | 7.02B | 9.16B | 7.74B | 9.25B | 7.76B | 9.70B | 9.42B | 2.97B | -15.02B | 10.47B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 15.96M | 7.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 863.80M | 3.09B | 6.32B | 1.92B | 3.24B | 4.53B | 4.60B | 6.15B | 5.42B | 4.75B | 7.02B | 9.16B | 7.74B | 9.25B | 7.76B | 9.70B | 9.42B | 2.97B | -15.02B | 10.47B |
| Basic earnings per share (Basic EPS) | 3.64 | 12.99 | 25.84 | 7.7 | 12.44 | 16.78 | 17.03 | 22.71 | 20.01 | 17.52 | 25.01 | 32.46 | 27.44 | 32.78 | 27.5 | 34.38 | 33.37 | 10.53 | -53.22 | 37.11 |
| Diluted earnings per share (Diluted EPS) | 3.21 | 11.56 | 24.96 | 7.5 | 12.42 | 16.76 | 17.01 | 22.69 | 20 | 17.52 | 25 | 32.45 | 27.43 | 32.78 | 27.5 | 34.38 | 33.37 | 10.53 | -53.22 | 37.1 |
| EBITDA | 1.35B | 4.24B | 7.95B | 4.48B | 6.49B | 5.92B | 7.14B | 10.10B | 12.97B | 11.44B | 14.33B | 20.37B | 16.17B | 14.77B | 16.32B | 21.09B | 23.69B | 16.70B | 12.32B | 23.82B |
| EBIT | 1.11B | 3.80B | 7.23B | 3.44B | 5.29B | 4.98B | 6.16B | 8.83B | 10.80B | 8.84B | 11.69B | 14.60B | 12.63B | 11.51B | 12.15B | 16.65B | 18.82B | 11.01B | 6.50B | 18.96B |
| Total operating expenses | -5.65B | -8.09B | -12.11B | -16.96B | -19.04B | -24.51B | -34.04B | -41.29B | -48.44B | -56.37B | -63.92B | -76.19B | -78.11B | -85.74B | -93.31B | -91.93B | -104.23B | -104.82B | -111.63B | -114.26B |
| Prepaid expenses | 36.05M | — | — | 531.74M | 491.53M | — | — | — | — | — | — | — | — | 1.32B | 1.46B | 2.20B | 2.20B | 2.27B | 266.90M | 1.05B |
| Deferred income, current | — | — | — | — | — | — | — | — | 9.40M | 413.08M | 192.27M | — | — | — | — | — | — | — | — | — |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.31B | 2.31B | 2.24B | 2.00B | 1.52B | 1.52B | 1.86B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 499.93M | 812.69M | 1.15B | 1.05B | 1.28B | 1.48B | 1.50B | 1.77B | 2.07B | 2.80B | 2.67B | 3.00B | 4.63B | 68.56M | 164.48M | 287.49M | 314.95M | 5.14M | 2.80M | 585.88M |
| Deferred income, non-current | 0 | — | — | 0 | 0 | 0 | 743.89M | 817.26M | 462.32M | 1.17B | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 14.80M | 31.55M | 130.07M | 267.01M | 249.98M | 243.64M | 132.80M | -1.87M | -3.01M | -4.23M | -3.70M | -3.77M | -3.92M | -3.54M | 3.51B | 3.65B | -3.80M | -3.71M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -165.59M | -95.31M | -171.75M | 0 | -100.97M | -125.82M | -126.09M | -642.56M | -631.91M | -634.65M | -678.53M | -678.05M | -678.82M | -678.81M | -685.54M | -704.47M | -926.95M | -1.37B | -1.18B | -704.42M |
| Preferred dividends paid | -14.00M | -6.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800